Methods: This systematic review was conducted using preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. Four databases were searched for RCTs of supportive-care interventions for adults with brain tumors, primary or metastatic, that included a patient-reported HRQoL outcome. Quality of the included studies was assessed using the Effective Public Health Practice Project Quality Assessment Tool for Quantitative Studies.
2017, and an estimated 20% to 40% of cancer patients will develop brain metastases. 3 This means that when considered jointly, primary brain tumors and brain metastases are more prevalent than newly diagnosed lung, breast, prostate, or colorectal cancer. 4 The sequelae of brain malignancies and their treatment are often complex and associated with functional impairment as well as significant psychosocial distress. 5 Brian tumors are unique compared with other cancers because progressive neurological deterioration can lead to personality changes and cognitive and functional decline, which can magnify the impact on quality of life and health-related quality of life 6 (HRQoL) specifically. 7 HRQoL has been defined as "a multi-dimensional concept that includes domains related to physical, mental, emotional, and social functioning. The need for supportive-care interventions-broadly defined in this review as psychosocial/behavioral, pharmacological, complementary, or alternative interventions-to improve HRQoL among brain tumor patients has been emphasized and noted as an important and emerging area. 5, [12] [13] [14] To date, three reviews have considered supportive-care interventions in patients with brain tumors. 12, 14, 15 In 2015, a scoping review about psychotherapy interventions for managing anxiety and depressive symptoms in adults with brain tumors 14 
| Search strategy
Following preferred reporting items for systematic reviews and metaanalyses (PRISMA) guidelines, 28 a systematic search was conducted using the EBSCOhost, ProQuest, PubMed, and Web of Science interfaces to search CINAHL, PsycINFO, PubMed, and Web of Science databases, respectively. A preliminary search of PubMed with the keywords "brain neoplasm" and "quality of life" was used to identify relevant medical subject headings (MeSH) terms. Next, the National
Center for Biotechnology Information (NCBI) MeSH database was used to find synonyms to ensure comprehensiveness of search terminology. Key terms to help identify the type of intervention (eg, "behavioral," "psychotherapy") and type of study design (eg, "randomized") and to exclude studies focused on children (eg, NOT "pediatric"),
were also identified. Final search terms used for the PubMed search are delineated in 16 and identified studies were conducted.
| Study selection
First, the citations that were identified via the PubMed search were exported into EndNote, version X8. Next, citations identified via each subsequent search of the additional databases (ie, CINAHL, PsycINFO, and Web of Science) were imported to the same database using the "Import into Duplicates Library" function; thus, data from the search phase was preserved in full, and duplicates were removed from the central database automatically. After an initial database was created, one author screened all titles and abstracts for potential inclusion (see inclusion and exclusion criteria above) and moved any missed duplicates into the duplicates database. The main reasons why studies were excluded at this stage were that they were a review article/commentary, the focus of the intervention was on primary treatment of the brain tumor, and/or the study was not an RCT. During the full-text review phase, the reasons why studies were deemed ineligible were the study design was not an RCT (eg, Khan et al 30 
| Data extraction
The following information was extracted from the studies: study design, participant characteristics (sample size at baseline, post intervention, and last follow-up assessment; diagnosis; mean time since diagnosis; mean age; percentage of women in the sample; language in which the study was conducted; and country in which the study was conducted), brain tumor treatment (radiotherapy, chemotherapy, and neurosurgical intervention), intervention characteristics (intervention, primary targeted intervention outcome, and brief descriptions of the arms of the study/intervention and control groups), HRQoL PRO measure(s) and assessment intervals, HRQoL results, and additional psychosocial results.
| Risk of bias
The methodological quality of the studies was examined using the Effective Public Health Practice Project (EPHPP) Quality Assessment Tool for Quantitative Studies. 37 Each of the studies was rated on the following six criteria: (a) selection bias, (b) study design, (c) confounders, (d) blinding, (e) data collection methods, and (f) withdrawals and dropouts. For these six criteria, a rating of "strong," "moderate," or "weak" was applied based on the EPHPP Quality Assessment Tool for Quantitative Studies Dictionary. Based on the total of each criterion rating, each study was assigned an overall global rating of "strong"
(no component was rated as weak), "moderate" (only one component was rated as weak), or "weak" (two or more components were rated as weak). Information about intervention integrity and analysis appropriate to the question was also summarized in Supplementary Table 2.
| Data analysis
A narrative method was used to summarize the results.
3 | RESULTS
| Study selection
Database searches yielded 671 relevant titles and abstracts. Subsequent backward and forward searches yielded four more titles and abstracts. After duplicates were removed, 549 titles and abstracts were screened for inclusion. Finally, 34 full text articles that appeared to meet criteria were read and evaluated. Ultimately, 10 studies across 11 articles were included in the review. 
| Study characteristics

| Participant characteristics
The 10 studies included 640 participants (baseline sample range: 19-140 participants) with either a primary or metastatic brain tumor.
None of the studies focused on patients with brain metastases only.
Two of the 10 studies included patients with both primary brain tumors and brain metastases. 4, 38 The remaining eight studies focused on patients with primary brain tumors; patients with a wide array of tumor types and grades were included in these studies. Astrocytoma grade II, 39 gliomas grades II to III, 40 gliomas grades II to IV, 41,42 glioma or meningioma grades I to IV, [43] [44] [45] and a wide range of tumor types, including benign, low-grade, and high-grade tumors (ie, glioblastoma multiforme, oligodendroglioma, astrocytoma, meningioma, pituitary tumor, colloid cyst, and craniopharyngioma). 16 Only one study included a homogenous sample in terms of tumor type and grade. 39 Three (out of 10) studies reported the mean time since diagnosis:
2.6 years (SD = 4.3), 16 4.13 years (SD = N.R.), 43 and 5.65 years (SD = N.R.). 40 Although many of the studies did not report mean time since diagnosis, the target intervention of the study reportedly took place during radiotherapy (RT). 4, 38, 41, 44, 45 The mean age of the participants in each sample ranged from 42.9 to 59 years. Most of the studies reported on samples with majority (>50%) male participants, with the exception of Page et al 45 Boele et al 43 
| Intervention characteristics
Of the 10 studies included in the review, four were psychosocial/ 
| Quality of the studies
Results obtained using the EPHPP Quality Assessment Tool for Quantitative Studies 37 are detailed in received a "weak" rating. Only RCTs were included in this review; thus, all of the studies received strong ratings for study design. Weak FIGURE 1 PRISMA diagram. This figure illustrates study identification and selection ratings were driven by selection bias (eg, it was unlikely that participants were representative of the target population or this information could not be ascertained; less than 60% of the individuals contacted agreed to participate or this information could not be ascertained; n = 5), lack of blinding (n = 3), confounders (n = 1), and withdrawals and dropouts (n = 3). In addition to these quality ratings, five studies noted being potentially underpowered to detect true effects. 16, 38, 41, 42, 44 Narrative summaries of intervention integrity and analysis appropriate to question for each study are presented in Supplementary Table 2.
| Efficacy of interventions for improving HRQoL
Only two interventions-home-based psychosocial intervention 16 and individualized acupuncture plus standard rehabilitation 39 -were able to demonstrate statistically significant improvement in HRQoL over the control condition used in their studies, waitlist control and standard rehabilitation alone, respectively. For the home-based psychosocial intervention study, 16 at baseline participants in the intervention condition reported lower levels of existential well-being, HRQoL, and emotional well-being than did participants in the waitlist control condition, despite being randomized to the two conditions. Following the intervention, controlling for baseline scores and relevant covariates, the intervention group reported statistically and clinically signifi- b Information reported for the "Glioma total group" (ie, glioma intervention group, excluding seven participants who were randomized to the intervention group but did not start the intervention and the glioma waiting list control group; information about the non-CNS control group has not been reported. Note. There were no significant differences by treatment arm on HRQoL at any point. Ten studies were identified. Three of the studies received a quality rating of "strong", three of "moderate", and four of "weak". Of the studies included in this review, only two interventions 16, 39 were associated with significant improvements in HRQoL relative to control conditions. Of note, these two studies received quality ratings of moderate 16 and strong. 39 Thus, there is evidence that psychosocial inter- All of the studies used measures that have been shown to be valid and reliable in previous studies among brain tumor patients. Yet none of the studies reported any psychometric properties (eg, Cronbach α) for their specific sample. Thus, all of the studies received a rating of "moderate" in this category.
b Despite nationwide recruitment efforts, which would have likely yielded a representative sample, of the glioma participants screened for eligibility, fewer than 60% of patients agreed to participate in the intervention. Thus, selection bias was rated "weak."
c On the basis of the description of recruitment, participants were likely aware of the research question.
d Authors noted that neuropsychology assessors were blinded to group allocation. On the basis of the type of intervention, participants were likely aware of the research question.
e Authors noted, "The 2 randomly assigned groups were well balanced" (p. 3778).
f Only 55% of participants completed the HRQoL questionnaire at the final assessment.
g Although blinding technically was "not described," and therefore, should receive a "moderate" rating based on the EPHPP Assessment Tool Guidelines, it was inferred based on the type of intervention that blinding was not possible.
h Authors noted that it was not possible to blind experimenters or participants. However, different psychologists from the ones who completed therapy completed the outcome assessments.
i Blinding described as "observer-blinded" (p. 2).
internet-based Problem-Solving Therapy intervention for depres- 64 and the use of a historical, noncontemporaneous control group that either predate or postdates a treatment group 60 have been suggested as alternatives when randomization is not possible.
| Clinical implications
The limited number and heterogeneity of interventions included in this review limit the conclusions that can be drawn. Yet based on the present review, two intervention modalities hold promise for improving HRQoL among patients with brain tumors-a home-based psychosocial intervention 16 and individualized acupuncture combined with standard rehabilitation. 39 The two studies investigating these treatments showed significant HRQoL improvements over the control conditions and had moderate and strong quality ratings, respectively.
Although these two studies alone are not enough to develop guidelines for empirically supported treatments, they are a first step. More high-quality psychosocial and complementary interventions need to be developed and tested to inform evidence-based practice and enhance the care of patients with brain tumors.
| Limitations
Limitations to the present review should be noted. The search was lim- 
| CONCLUSION
Brain tumor patients desire interventions that will help them redefine hope and improve their HRQoL. 67 The current review was only able to identify two RCTs where the intervention group showed significant improvement in HRQoL over the control group(s)-a home-based psychosocial intervention 16 and individualized acupuncture combined with standard rehabilitation. 39 Yet efforts are underway to further explore acupuncture 68 and psychosocial interventions 5 with respect to effects on HRQoL in these patients. In a recent commentary, Ownsworth 5 described some of the exciting recent psychosocial advancements in the management of primary brain tumors as well as future directions that take into account logistical barriers to providing face-to-face psychotherapy, such as tele-health and family-based support. Additionally, some of the most recent efforts toward supportive care interventions that may show promise at improving HRQoL in patients with brain tumors include a rehabilitation intervention of physical and occupational therapy, 69 ketogenic diets, 70 cranial electrotherapy stimulation, 71 and virtual reality. 72 All of these efforts provide hope for this growing field. Ultimately, HRQoL must be prioritized in patients with brain tumors throughout treatment and beyond. Supportive-care interventions can serve as tools to improve patient care with respect to HRQoL in this fragile population, but more high-quality research on these interventions is needed to guide clinical decision-making.
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